Does METOPIMAZINE Cause Interstitial lung disease? 21 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 21 reports of Interstitial lung disease have been filed in association with METOPIMAZINE. This represents 4.9% of all adverse event reports for METOPIMAZINE.
21
Reports of Interstitial lung disease with METOPIMAZINE
4.9%
of all METOPIMAZINE reports
0
Deaths
21
Hospitalizations
How Dangerous Is Interstitial lung disease From METOPIMAZINE?
Of the 21 reports, 21 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METOPIMAZINE. However, 21 reports have been filed with the FAERS database.
What Other Side Effects Does METOPIMAZINE Cause?
Acute kidney injury (35)
Toxicity to various agents (34)
Coma (30)
Foetal exposure during pregnancy (26)
Bradycardia (25)
Intentional overdose (24)
Nausea (24)
Poisoning deliberate (24)
Vomiting (24)
Hyperkalaemia (23)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which METOPIMAZINE Alternatives Have Lower Interstitial lung disease Risk?
METOPIMAZINE vs METOPROLOL
METOPIMAZINE vs METRELEPTIN
METOPIMAZINE vs METRONIDAZOLE
METOPIMAZINE vs METRONIDAZOLE\METRONIDAZOLE
METOPIMAZINE vs METYRAPONE